Abstract
Myocytes from failing human ventricle contract and relax more slowly than those from non-failing. This has been suggested to result from the lowering of basal cyclic AMP level in failing myocardium, and the consequent withdrawal of a tonic lusitropic effect. We present data to support this hupothesis by demonstrating that the acceleration of contraction and relaxation by β-adrenoceptor stimulation is greater in myocytes from failing than nonfailing heart. This is despite the desensitisation of the inotropic effect of isorenaline in the same failing cells. Following β-adrenoceptor stimulation, speeds of contraction and relaxation are normalised in myocytes from failing heart, with final values not significantly different from non-failing.
Similar content being viewed by others
References
Beuckelmann DJ, Erdmann E (1992) Ca(2+)-currents and intracellular [Ca2+]i-transients in single ventricular myocytes isolated from terminally failing human myocardium. Basic Res Cardiol 87 Suppl 1: 235–243
Bohm M, Reiger B, Schwinger RHG, Erdmann E (1994) cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc Res 28: 1713–1719
Danielsen W, v der Leyen H, Meyer W et al. (1989) Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations. J Cardiovasc Pharmacol 14: 171–173
Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA, Harding SE (1995) Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92: 2540–2549
del Monte F, O'Gara P, Poole-Wilson PA, Yacoub MH, Harding SE (1995) Cell geometry and contractile abnormalities of myocytes from failing human left ventricle. Cardiovasc Res 30: 281–290
Gwathmey JK, Copelas L, MacKinnon R et al. (1987) Abnormal calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61: 70–76
Harding SE, Jones SM, O'Gara P, del Monte F, Vescovo G, Poole-Wilson PA (1992) Isolated ventricular myocytes from failing and non-failing human heart; the relation of age and clinical status of patients to isoproterenol response. J Mol Cell Cardiol 24: 549–564
Harding SE, Jones SM, Vescovo G, del Monte F, Poole-Wilson PA (1992) Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle. Eur J Pharmacol 223: 39–48
Regitz-Zagrosek V, Hertrampf R, Steffen C, Hidebrandt A, Fleck E (1994) Myocardial cyclic AMP and norepinephrine content in human heart failure. Eur Heart J 15D: 7–13
Schwinger RH, Bohm M, Erdmann E (1992) Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy. Am Heart J 123: 116–128
Schwinger RHG, Bohm M, Muller-Ehmsen J et al. (1993) Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart. Circulation 88: 2267–2276
von der Leyen H, Mende U, Meyer W et al. (1991) Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations. Naunyn-Schmiedeberg's Arch Pharmacol 344: 90–100
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harding, S.E., Brown, L.A., del Monte, F. et al. Acceleration of contraction by β-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts. Basic Res Cardiol 91 (Suppl 1), 53–56 (1996). https://doi.org/10.1007/BF00795363
Issue Date:
DOI: https://doi.org/10.1007/BF00795363